OSE Immunotherapeutics delays H1 2026 results amid financing talks
The company deferred publication of its H1 2026 financial statements and interim report to a later date.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.